Brandon Tolany's Insider Trades & SAST Disclosures
Brandon Tolany's most recent trade in Silicon Laboratories Inc was a trade of 53 Common Stock, $0.0001 par value done at an average price of $77.5 . Disclosure was reported to the exchange on Dec. 28, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Brandon Tolany.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Silicon Laboratories Inc | Brandon Tolany | Sr VP WW Sales & Marketing | Grant, award, or other acquisition of securities at price $ 77.47 per share. | 28 Dec 2024 | 53 | 43,668 (0%) | 0% | 77.5 | 4,106 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | Sr VP WW Sales & Marketing | Sale of securities on an exchange or to another person at price $ 115.00 per share. | 03 Sep 2024 | 845 | 43,615 (0%) | 0% | 115 | 97,175 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | Sr VP of Worldwide Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 8,784 | 44,460 (0%) | 0% | 0 | Common Stock, $0.0001 par value | |
| Silicon Laboratories Inc | Brandon Tolany | Sr VP of Worldwide Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.57 per share. | 15 May 2024 | 4,721 | 35,676 (0%) | 0% | 131.6 | 621,142 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | Sr VP of Worldwide Sales | Grant, award, or other acquisition of securities at price $ 77.49 per share. | 30 Apr 2024 | 49 | 40,397 (0%) | 0% | 77.5 | 3,797 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Tolany Brandon | Sr VP of Worldwide Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 6,829 | 40,348 (0%) | 0% | 0 | Common Stock, $0.0001 par value | |
| Silicon Laboratories Inc | Brandon Tolany | Sr VP of Worldwide Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 4,798 | 33,471 (0%) | 0% | 0 | Common Stock, $0.0001 par value | |
| Silicon Laboratories Inc | Brandon Tolany | Sr VP of Worldwide Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 136.32 per share. | 15 May 2023 | 1,563 | 28,673 (0%) | 0% | 136.3 | 213,068 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | Sr VP of Worldwide Sales | Grant, award, or other acquisition of securities at price $ 100.85 per share. | 28 Apr 2023 | 41 | 30,236 (0%) | 0% | 100.9 | 4,135 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | Sr VP of Worldwide Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 188.45 per share. | 15 Feb 2023 | 640 | 30,195 (0%) | 0% | 188.5 | 120,608 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | Sr VP of Worldwide Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 156.91 per share. | 31 Jan 2023 | 1,046 | 30,835 (0%) | 0% | 156.9 | 164,128 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | Sr VP of Worldwide Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 3,478 | 31,881 (0%) | 0% | 0 | Common Stock, $0.0001 par value | |
| Silicon Laboratories Inc | Brandon Tolany | Sr VP of Worldwide Sales | Grant, award, or other acquisition of securities at price $ 100.85 per share. | 31 Oct 2022 | 41 | 28,403 (0%) | 0% | 100.9 | 4,135 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 5,459 | 28,362 (0%) | 0% | 0 | Common Stock, $0.0001 par value | |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 143.62 per share. | 13 May 2022 | 770 | 22,903 (0%) | 0% | 143.6 | 110,587 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Grant, award, or other acquisition of securities at price $ 114.66 per share. | 29 Apr 2022 | 35 | 23,673 (0%) | 0% | 114.7 | 4,013 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 160.97 per share. | 15 Feb 2022 | 1,878 | 24,624 (0%) | 0% | 161.0 | 302,302 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Sale of securities on an exchange or to another person at price $ 157.98 per share. | 15 Feb 2022 | 986 | 23,638 (0%) | 0% | 158.0 | 155,768 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Grant, award, or other acquisition of securities at price $ 119.82 per share. | 29 Oct 2021 | 33 | 26,502 (0%) | 0% | 119.8 | 3,954 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Sale of securities on an exchange or to another person at price $ 151.38 per share. | 21 Oct 2021 | 4,953 | 26,469 (0%) | 0% | 151.4 | 749,785 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Oct 2021 | 2,149 | 18,270 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.82 per share. | 21 Oct 2021 | 2,149 | 31,422 (0%) | 0% | 43.8 | 94,169 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Sale of securities on an exchange or to another person at price $ 150.29 per share. | 19 Oct 2021 | 3,302 | 29,993 (0%) | 0% | 150.3 | 496,258 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Oct 2021 | 1,302 | 20,793 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.82 per share. | 19 Oct 2021 | 1,302 | 33,295 (0%) | 0% | 43.8 | 57,054 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Sale of securities on an exchange or to another person at price $ 150.17 per share. | 19 Oct 2021 | 1,094 | 29,273 (0%) | 0% | 150.2 | 164,286 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Oct 2021 | 374 | 20,419 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.82 per share. | 19 Oct 2021 | 374 | 30,367 (0%) | 0% | 43.8 | 16,389 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | Sr VP of Worldwide Sales | Sale of securities on an exchange or to another person at price $ 153.19 per share. | 07 Sep 2021 | 12,751 | 31,993 (0%) | 0% | 153.2 | 1,953,326 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | Sr VP of Worldwide Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2021 | 5,275 | 22,095 | - | - | Non-Qualified Stock Option (right to buy) | |
| Silicon Laboratories Inc | Brandon Tolany | Sr VP of Worldwide Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.82 per share. | 07 Sep 2021 | 5,275 | 44,744 (0%) | 0% | 43.8 | 231,151 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2021 | 5,267 | 39,469 (0%) | 0% | 0 | Common Stock, $0.0001 par value | |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Grant, award, or other acquisition of securities at price $ 82.65 per share. | 30 Apr 2021 | 48 | 34,202 (0%) | 0% | 82.6 | 3,967 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Sale of securities on an exchange or to another person at price $ 152.92 per share. | 16 Feb 2021 | 1,921 | 34,154 (0%) | 0% | 152.9 | 293,759 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 154.34 per share. | 12 Feb 2021 | 3,461 | 36,075 (0%) | 0% | 154.3 | 534,171 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Sale of securities on an exchange or to another person at price $ 132.30 per share. | 01 Feb 2021 | 379 | 39,536 (0%) | 0% | 132.3 | 50,142 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 1,720 | 40,374 (0%) | 0% | 0 | Common Stock, $0.0001 par value | |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.17 per share. | 28 Jan 2021 | 459 | 39,915 (0%) | 0% | 131.2 | 60,207 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Grant, award, or other acquisition of securities at price $ 82.65 per share. | 30 Oct 2020 | 48 | 38,654 (0%) | 0% | 82.6 | 3,967 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Sale of securities on an exchange or to another person at price $ 105.13 per share. | 21 Jul 2020 | 16,170 | 38,606 (0%) | 0% | 105.1 | 1,699,952 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jul 2020 | 9,100 | 27,370 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.82 per share. | 21 Jul 2020 | 9,100 | 54,776 (0%) | 0% | 43.8 | 398,762 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Brandon Tolany | SR VP of Worldwide Sales | Grant, award, or other acquisition of securities at price $ 82.64 per share. | 30 Apr 2020 | 47 | 45,676 (0%) | 0% | 82.6 | 3,884 | Common Stock, $0.0001 par value |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges